Cynvenio Ships Genomic Testing System

Los Angeles-based Cynvenio Biosystems said yesterday that it has shipped its LiquidBiopsy, genetic testing system for blood samples, with nationwide availability of the product. The company develops a platform which is aimed at doctors and cancer researchers, and performs next-generation sequencing (NGS) on the tumor cells in whole blood, aimed at helping in monitoring cancer and for cancer diagnostics. The company's equipment is able to detect even very low levels of tumor cells in the bloodstream.